Back
Immunovant 10K Form
Sell
28
IMVT
Immunovant
Last Price:
28.50
Seasonality Move:
10.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMVT News And Ratings
See the #1 stock for the next 7 days that we like better than IMVT
IMVT Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-47.23M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.68 |
| Price / Book: | 5.88 |
Profitability
| EPS (TTM): | -1.84000 |
|---|---|
| Net Income (TTM): | $-243.45M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Immunovant Earnings Forecast
Key Immunovant Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Immunovant Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMVT |
| CUSIP: | 45258J |
| Website: | immunovant.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IMVT Technical Analysis vs Fundamental Analysis
Sell
28
Immunovant (IMVT)
is a Sell
Is Immunovant a Buy or a Sell?
-
Immunovant stock is rated a Sell
The current Immunovant [IMVT] share price is $27.47. The Score for IMVT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.